M. Kamil, M., Jabarah, M. A.-. H., & A.l. Jasim, N. (2023). Immunogenicity of the biosimilar CT-P13 infliximab or the original infliximab in Iraqi patients with Ankylosing spondylitis does not correlate with their demographic characteristics. Journal of the Faculty of Medicine Baghdad, 64(4), 261-267. https://doi.org/10.32007/jfacmedbagdad.6441969